echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Saisheng Pharmaceuticals and SF Pharmaceuticals Sign Strategic Cooperation Agreement

    Saisheng Pharmaceuticals and SF Pharmaceuticals Sign Strategic Cooperation Agreement

    • Last Update: 2021-07-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Saisheng Pharmaceutical Holdings Co.
    , Ltd.
    and SF Pharmaceuticals officially announced that they will start a strategic cooperation on April 22, 2021, and SF Pharmaceuticals has become a GTP supply chain service provider certified by Saisheng Pharmaceuticals
    .


    The two parties will give full play to their respective advantages - relying on Saisheng Pharmaceutical's professional and deep cultivation in the field of life and health and SF Pharmaceutical's successful practice in the integrated digital supply chain and innovative operation model, to work together to create a more efficient life and health enterprise to C-end patient users Provide professional, safe, and traceable end-to-end services to build a higher standard for China’s GTP supply chain in the field of life and health


    The signing ceremony of the strategic cooperation agreement was held in Beijing
    .


    Mr.


    At the signing ceremony, Mr.
    Zhao Hong, President and CEO of Saisheng Pharmaceutical, and Ms.
    Zhou Shun, General Manager of SF Pharmaceutical, successively discussed the overall plan for strategic cooperation between the two parties and the innovative Go-To-Patient ("GTP") business model of Saisheng Pharmaceutical And SF's medical service information visualization innovative business model was shared and exchanged
    .


    Saisheng Pharmaceutical's GTP platform expands the sales channels of prescription drugs from hospitals to Direct-To-Patient ("DTP") pharmacies, increasing the availability of prescription drugs to patients


    Mr.
    Li Zhenfu, Chairman of Saisheng Pharmaceutical, Chairman and CEO of Telford Capital, said at the signing ceremony: “As an international biopharmaceutical company with an integrated platform for product development and commercialization, Saisheng Pharmaceutical has been deeply involved in China for more than 20 years.
    upload
    Isa Pharma since its inception, has been the health of patients, and insist that 'strict compliance, high performance' culture, provided the original research of high-quality products that meet international standards for patients
    .


    whether it is the core of its own products Zadaxin (thymalfasin New original research drugs), or the other 8 products under development, all have a huge market and continued high volume prospects in the field of oncology and anti-infection


    Mr.


    Lu Jun, Chairman of SF Pharmaceuticals, said in a speech: "We are very honored to be certified by Saisheng Pharmaceuticals, and we are full of confidence in this strategic cooperation


    Value first, mutual empowerment, and common improvement
    .


    Saisheng Pharmaceutical Co.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.